Home › Collections › All liver disease samples

All liver disease samples

Disease reference sets · collection id liver-disease-samples

Every gut sample whose curated health_condition is liver disease (cirrhosis, hepatitis, hepatocellular carcinoma, hepatic encephalopathy), across all studies.

Open in the sample explorer (5,480 samples)

50
studies with member samples
5,480
member samples in this release

Membership rule

health_conditionliver_disease
body_site_classprimary

Composition

Age category
unknown2,777
adult2,427
elderly173
child93
adolescent10
Country
US2,707
CN690
DK350
HU302
ES221
DE176
Health condition
liver_disease Liver disease (cirrhosis5,480

Member studies (50)

StudyTitleMember samplesFirst public
PRJNA912122Lactulose-mediated Bifidobacteria expansion promotes a beneficial fecal metabolite profile that is associated with exclusion of antibiotic-resistant pathogens and improved outcomes in advanced liver disease8502022
PRJEB102033Lantibiotic-producing bacteria impact microbiome resilience and colonization resistance5712025
PRJEB76661Metagenomic analysis of the gut microbiome in patients with alcohol-related liver disease3502024
PRJEB89898Metagenomic sequences of the fecal microbiome from patients with decompensated cirrhosis and ACLF3022025
PRJNA1425466Stool metagenome in primary billiary cholangitis (PBC)2802026
PRJNA1425460Stool metagenome in primary sclerosing cholangitis (PSC)2452026
PRJNA1372070Hepatocellular Carcinoma Cohort Metagenomics1962026
PRJEB40200Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics. Relationship with acute-on-chronic liver failure and mortality and prognosis.1812020
PRJNA1227423Metagenomic shotgun sequencing data of fecal samples from a liver disease cohort1762025
PRJEB73985Oat beta glucan versus iso dietary fiber or placebo in MASLD: A multicenter, randomized, placebo-controlled dietary study1752025
PRJEB6337Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues.1692014
PRJNA1039781Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection1432023
PRJNA1491285Gut microbiota in patients with cirrhosis and portal hypertension receiving lactulose1432026
PRJDB28938Multi-omics reveal host-microbiota interactions in primary biliary cholangitis (PRJCA018532)1322026
PRJNA1184735Fecal butyrate and deoxycholic acid concentrations correlate with mortality in hospitalized patients with liver disease1222024
PRJEB38481Liver Cirrhosis cohort902021
PRJNA608022human viral metagenome Raw sequence reads882020
PRJNA1203401Gut microbiota predicts treatment response to empagliflozin among MASLD patients without diabetes mellitus872025
PRJNA622386Human feces viral metagenome raw sequence reads associated with NAFLD862020
PRJNA546034NAFLD Microbiome862019
PRJNA766067The Mucosally-Adherent Rectal Microbiota Contains Features Unique to Alcohol-Related Cirrhosis842021
PRJNA1317556Microbiome and metabolome characteristics of the small intestine in patients with ACLF802025
PRJEB14215The role of the intestinal microflora in non-alcoholic fatty liver disease (NAFLD) (FP7)732018
PRJNA1308792Microbial diversity in patients with alcoholic liver disease562025
PRJNA1234627Resistant starch intervention in patients with MASLD552025
PRJNA1104421Serum Bile Acids profiles are altered without change of the Gut Microbiota composition following a seven-day prednisolone therapy in severe alcoholic hepatitis542024
PRJNA1372073Hepatocellular Carcinoma Cohort Metagenomics522026
PRJNA1111312Shotgun metagenomics reveals Bacteroides stercoris as a fecal biomarker depleted in late-stage hepatocellular carcinoma512024
PRJNA373901Novel gut-microbiota based metagenomic signature for advanced fibrosis in nonalcoholic fatty liver disease502017
PRJNA1398904Enterococcus faecium Driven Metabolic Dysbiosis is Linked to Mortality following Liver Transplant422026
PRJEB11419American Gut Project402015
PRJNA1377628Decoding the microbiome and resistome of advanced chronic liver disease through long-read metagenomics362026
PRJNA1144402Patients Infected with the Hepatitis D Virus have a Unique Gut Microbiome with Distinguishing Microbial and Functional Features352026
PRJEB60097Microbiome in health and disease312023
PRJNA1177516Changes in Fecal Microbiota in Adults with Cystic Fibrosis with 6 Months of CFTR Modulator Therapy Elexacaftor/Tezacaftor/Ivacaftor (ETI)302025
PRJNA730640The composition of gut microbiota in biliary atresia302021
PRJNA1172418Development of a model predicting 90-day survival in severe alcohol-related hepatitis using a retrospective cohort302025
PRJEB18041"Shotgun" gut metagenomes of the patients with alcohol dependence syndrome and alcoholic liver cirrhosis272016
PRJNA1092365Raw data used for stduying interaction between bile acid and gut microbiome232025
PRJNA1334189The gut microbiome of human liver diseases222025
PRJNA970820human gut metagenome Genome sequencing and assembly212023
PRJNA517801WGS_Liver_disease212019
PRJNA1438274Proximity-ligation metagenomics of rCDI and Cirrhosis Patients192026
PRJNA328258feces metagenome Metagenome172022
PRJDB10484Gut microbial species responsible for hyperammonemia-related urease activity in hepatic encephalopathy patients122022
PRJNA1167913Metagenomic sequencing of human fecal samples from NAFLD and non-NAFLD patients infected with HIV62024
PRJDB5180A metagenomic approach for acute cholecystitis patients enables pathogen detection and rapid diagnostics52017
PRJNA1468588Gut microbiome dynamics in a primary sclerosing cholangitis patient treated with vancomycin42026
PRJNA624763Shotgun metagenomics of human gut microbiota in China high longevity area12020
PRJNA850529Host factors associated with gut mycobiome structure12023